Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Infinium Pharmachem IPO is a fixed price issue of ₹25.25 crores. The issue is entirely a fresh issue of 0.19 crore shares of ₹25.25 crore.
Infinium Pharmachem IPO bidding started from Mar 31, 2023 and ended on Apr 5, 2023. The allotment for Infinium Pharmachem IPO was finalized on Apr 11, 2023. The shares got listed on NSE SME on Apr 17, 2023.
Infinium Pharmachem IPO price is ₹135.00 per share . The lot size for an application is 1,000. The minimum amount of investment required by an individual investor (retail) is ₹1,35,000 (1000 shares). The minimum lot size investment for HNI is 2 lots (2,000 shares), amounting to ₹2,70,000.
The issue includes a reservation of up to 41,000 shares for employees offered at a discount of ₹13.50 to the issue price.
Swastika Investmart Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The market maker of the company is Swastika Investmart Ltd..
Refer to Infinium Pharmachem IPO RHP for detailed Information.
| IPO Date | March 31, 2023 to April 5, 2023 |
| Listing Date | April 17, 2023 |
| Face Value | ₹10 per share |
| Issue Price Band | |
| Issue Price Final | ₹135 per share |
| Lot Size | 1,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 18,75,000 shares (aggregating up to ₹25.25 Cr) |
| Reserved for Market Maker | 94,000 shares Swastika Investmart Ltd. (aggregating up to ₹1.27 Cr) |
| Net Offered to Public | 17,81,000 shares (aggregating up to ₹23.99 Cr) |
| Employee Discount | ₹13.50 |
| Issue Type | Fixed Price IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 50,83,060 shares |
| Share Holding Post Issue | 69,58,060 shares |
Infinium Pharmachem IPO offers total 18,75,000 shares. Out of which 8,70,000 (46.40%) allocated to NII, 8,70,000 (46.40%) allocated to RII.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 94,000 (5.01%) |
| NII (HNI) Shares Offered | 8,70,000 (46.40%) |
| Retail Shares Offered | 8,70,000 (46.40%) |
| Employee Shares Offered | 41,000 (2.19%) |
| Total Shares Offered | 18,75,000 (100.00%) |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only RII | Up to Rs 2 Lakhs | Yes |
| Only NII | Above Rs 2 Lakhs | No |
| Only employee | Yes | |
| Employee + RII/NII |
|
Yes for Employee and RII/NII |
Infinium Pharmachem IPO opens on March 31, 2023, and closes on April 5, 2023.
| IPO Open Date | Fri, Mar 31, 2023 |
| IPO Close Date | Wed, Apr 5, 2023 |
| Tentative Allotment | Tue, Apr 11, 2023 |
| Initiation of Refunds | Wed, Apr 12, 2023 |
| Credit of Shares to Demat | Thu, Apr 13, 2023 |
| Tentative Listing Date | Mon, Apr 17, 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on Wed, Apr 5, 2023 |
Investors can bid for a minimum of 1,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,000 | ₹1,35,000 |
| Retail (Max) | 1 | 1,000 | ₹1,35,000 |
| HNI (Min) | 2 | 2,000 | ₹2,70,000 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 2003, Infinium Pharmachem Limited manufactures & supplies Iodine Derivatives, APIs, and Iodination reaction-based bulk drugs.
The company offers R & D services and commercial scale manufacturing and packaging for Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals & other chemical industries.
Infinium Pharmachem's manufacturing plant is located in Gujarat - INDIA, which spans across 4100 Sq. Mtr. Plot area. The facility is FDA certified & GMP compliant with capabilities of producing complex Iodine Derivatives.
The company serves to over 15+ countries across the globe and has over 200+ Iodine Derivatives and 7+ APIs.
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Total Borrowing |
|---|---|---|---|---|---|
| 31-Mar-20 | 2,244.60 | 3,941.64 | 93.40 | 424.74 | 566.17 |
| 31-Mar-21 | 3,418.27 | 7,115.37 | 272.48 | 702.32 | 579.47 |
| 31-Mar-22 | 5,899.95 | 10,005.25 | 610.64 | 1,310.22 | 1,385.01 |
| 30-Sep-22 | 7,075.71 | 7,985.39 | 551.01 | 1,855.77 | 1,614.71 |
| Amount in ₹ Lakhs | |||||
The market capitalization of Infinium Pharmachem IPO is ₹93.93 Cr.
| Pre IPO | Post IPO | |
|---|---|---|
| P/E (x) | 7.83 |
The proceeds from the fresh issue will be utilized for the following objects:
1. Marketing and branding expenses (including registration in reach - Europe, and other marketing expenses).
2. Repayment of some of the existing loans and expansion of units.
3. To meet incremental working capital requirements.
4. To meet public issue expenses.
[Dilip Davda] IPL is in the pharma and healthcare segment and has posted growth in its top and bottom lines for the reported periods. Super earnings for FY23 H1 raise eyebrows and concern over the sustainability of such margins going forward. Well-informed investors may park funds for medium to long-term rewards. Read detail review...
| Listing Date | April 17, 2023 |
| BSE Script Code | |
| NSE Symbol | INFINIUM |
| ISIN | INE0MRE01011 |
| Final Issue Price | ₹135 per share |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹135.00 |
| Open | ₹141.50 |
| Low | ₹141.50 |
| High | ₹148.55 |
| Last Trade | ₹147.80 |
Infinium Pharmachem Ltd.
38 G.I.D.C Sojitra,
Taluka,
Sojitra,
Anand, Gujarat, 387240
Phone: +91-2692-238849
Email: info@infiniumpharmachem.com
Website: https://infiniumpharmachem.com/
Bigshare Services Pvt.Ltd.
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
Infinium Pharmachem IPO is a SME IPO of 18,75,000 equity shares of the face value of ₹10 aggregating up to ₹25.25 Crores. The issue is priced at ₹135 per share. The minimum order quantity is 1000.
The IPO opens on March 31, 2023, and closes on April 5, 2023.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Infinium Pharmachem IPO using UPI as a payment gateway. Zerodha customers can apply in Infinium Pharmachem IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Infinium Pharmachem IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Infinium Pharmachem IPO opens on March 31, 2023 and closes on April 5, 2023.
Infinium Pharmachem IPO lot size is 1000, and the minimum amount required for application is ₹1,35,000.
You can apply in Infinium Pharmachem IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Infinium Pharmachem IPO will be done on Tuesday, April 11, 2023, and the allotted shares will be credited to your demat account by Thursday, April 13, 2023. Check the Infinium Pharmachem IPO allotment status.
The Infinium Pharmachem IPO listing date is on Monday, April 17, 2023.
Useful Articles
RHP